BreastCancer,bcsm,oncology

Mashup Score: 1

Dr Bardia on the Limitations of HER2 Testing Assays in HER2-Low and -Ultralow Breast Cancer - 3 month(s) ago

Aditya Bardia, MD, MPH, FASCO, discusses HER2 IHC testing in patients with HER2-low and -ultralow metastatic breast cancer.

Source: www.onclive.com

Categories: General Medicine News, Oncologists1

Tweet Tweets with this article
- OncLive
  
  🎥Listen in as @dradityabardia, of @UCLAHealth, discusses HER2 IHC testing in patients with HER2-low and -ultralow metastatic #BreastCancer. #bcsm #oncology 🚨WATCH here: https://t.co/1nB8r6DTG9 https://t.co/l0jr2oYRjO